GLP-1 receptor agonist medications are injections that may support with appetite suppression and weight loss by activating GLP-1 receptors in the pancreas, which increases insulin release and decreases glucagon release, slow stomach emptying which leads to less release of glucose into the bloodstream and increase satiety by impacting the areas of the brain that process hunger and satiety. Although the foundation of weight loss includes lifestyle changes, these medications may be a useful addition for qualifying patients. If interested, sign up for a foundational functional assessment or PCOS/Hormone Assessment.

Register Now